Chase Knickerbocker
Stock Analyst at Craig-Hallum
(4.97)
# 85
Out of 4,673 analysts
641
Total ratings
60.7%
Success rate
38.8%
Average return
Main Sectors:
Stocks Rated by Chase Knickerbocker
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| GRCE Grace Therapeutics | Reiterated: Buy | $4 | $2.20 | +81.82% | 20 | Aug 18, 2026 | |
| CELC Celcuity | Reiterated: Buy | $178 → $173 | $93.53 | +84.97% | 29 | Aug 18, 2026 | |
| BFLY Butterfly Network | Maintained: Buy | $10 | $9.55 | +4.71% | 24 | Aug 18, 2026 | |
| ETON Eton Pharmaceuticals | Reiterated: Buy | $62 → $76 | $63.47 | +19.74% | 39 | Aug 14, 2026 | |
| ACOG Alpha Cognition | Maintained: Buy | $17 | $9.75 | +74.36% | 5 | Aug 14, 2026 | |
| XTNT Xtant Medical Holdings | Rated: Buy | $0.6 | $0.3249 | +84.67% | 38 | Aug 12, 2026 | |
| FENC Fennec Pharmaceuticals | Rated: Buy | $18 | $11.29 | +59.43% | 34 | Aug 12, 2026 | |
| CVRX CVRx, Inc. | Maintained: Hold | n/a | $2.84 | - | 30 | Aug 11, 2026 | |
| DCTH Delcath Systems | Maintained: Buy | $24 | $17.14 | +40.02% | 28 | Aug 7, 2026 | |
| MYO Myomo | Maintained: Buy | $1.1 → $1.7 | $1.73 | -1.73% | 17 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $6 | $3.21 | +86.92% | 28 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $16 → $18 | $14.38 | +25.17% | 28 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $53 | $36.87 | +43.75% | 38 | Aug 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $20 | $8.87 | +125.48% | 35 | Jul 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $12 | $5.10 | +135.29% | 19 | Jul 22, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $4 | $0.78 | +412.82% | 2 | Jul 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $4.29 | - | 33 | Jul 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $59 | $40.95 | +44.08% | 45 | Jul 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $12 | $8.70 | +37.93% | 29 | Jul 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $4.33 | - | 44 | Jul 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $8.32 | - | 1 | Jul 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $16.44 | - | 1 | Jun 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $6.52 | - | 24 | Jun 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $6.15 | - | 12 | May 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $13.21 | - | 15 | Apr 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $61.89 | - | 1 | Nov 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $124.09 | - | 1 | Nov 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $66.61 | - | 1 | Oct 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $42.09 | - | 1 | Oct 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $286.29 | - | 3 | Oct 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $64.21 | - | 2 | Oct 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $4.32 | n/a | 1 | Jul 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $101.73 | n/a | 1 | Jul 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $10.28 | n/a | 1 | Jul 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $12 | $11.10 | n/a | 1 | Feb 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $5.25 | n/a | 1 | Feb 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | n/a | $35.58 | n/a | 1 | Aug 28, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $38 | $20.38 | n/a | 1 | Aug 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | n/a | $13.94 | n/a | 1 | Jul 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $10 | $4.33 | n/a | 1 | Mar 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | n/a | $4.96 | n/a | 1 | Oct 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | n/a | $1.69 | n/a | 1 | Sep 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | n/a | $24.95 | n/a | 1 | Aug 18, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | n/a | $12.21 | n/a | 1 | May 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $58 | $36.78 | n/a | 1 | May 3, 2023 |
Grace Therapeutics
Aug 18, 2026
Reiterated: Buy
Price Target: $4
Current: $2.20
Upside: +81.82%
Celcuity
Aug 18, 2026
Reiterated: Buy
Price Target: $178 → $173
Current: $93.53
Upside: +84.97%
Butterfly Network
Aug 18, 2026
Maintained: Buy
Price Target: $10
Current: $9.55
Upside: +4.71%
Eton Pharmaceuticals
Aug 14, 2026
Reiterated: Buy
Price Target: $62 → $76
Current: $63.47
Upside: +19.74%
Alpha Cognition
Aug 14, 2026
Maintained: Buy
Price Target: $17
Current: $9.75
Upside: +74.36%
Xtant Medical Holdings
Aug 12, 2026
Rated: Buy
Price Target: $0.6
Current: $0.3249
Upside: +84.67%
Fennec Pharmaceuticals
Aug 12, 2026
Rated: Buy
Price Target: $18
Current: $11.29
Upside: +59.43%
CVRx, Inc.
Aug 11, 2026
Maintained: Hold
Price Target: n/a
Current: $2.84
Upside: -
Delcath Systems
Aug 7, 2026
Maintained: Buy
Price Target: $24
Current: $17.14
Upside: +40.02%
Myomo
Aug 6, 2026
Maintained: Buy
Price Target: $1.1 → $1.7
Current: $1.73
Upside: -1.73%
Aug 6, 2026
Reiterated: Buy
Price Target: $6
Current: $3.21
Upside: +86.92%
Aug 6, 2026
Rated: Buy
Price Target: $16 → $18
Current: $14.38
Upside: +25.17%
Aug 4, 2026
Rated: Buy
Price Target: $53
Current: $36.87
Upside: +43.75%
Jul 31, 2026
Rated: Buy
Price Target: $20
Current: $8.87
Upside: +125.48%
Jul 22, 2026
Maintained: Buy
Price Target: $12
Current: $5.10
Upside: +135.29%
Jul 16, 2026
Reiterated: Buy
Price Target: $4
Current: $0.78
Upside: +412.82%
Jul 14, 2026
Maintained: Buy
Price Target: n/a
Current: $4.29
Upside: -
Jul 13, 2026
Reiterated: Buy
Price Target: $59
Current: $40.95
Upside: +44.08%
Jul 8, 2026
Rated: Buy
Price Target: $12
Current: $8.70
Upside: +37.93%
Jul 6, 2026
Maintained: Buy
Price Target: n/a
Current: $4.33
Upside: -
Jul 1, 2026
Maintained: Buy
Price Target: n/a
Current: $8.32
Upside: -
Jun 30, 2026
Maintained: Buy
Price Target: n/a
Current: $16.44
Upside: -
Jun 24, 2026
Maintained: Buy
Price Target: n/a
Current: $6.52
Upside: -
May 11, 2026
Maintained: Buy
Price Target: n/a
Current: $6.15
Upside: -
Apr 6, 2026
Maintained: Buy
Price Target: n/a
Current: $13.21
Upside: -
Nov 20, 2025
Maintained: Buy
Price Target: n/a
Current: $61.89
Upside: -
Nov 19, 2025
Maintained: Buy
Price Target: n/a
Current: $124.09
Upside: -
Oct 20, 2025
Maintained: Buy
Price Target: n/a
Current: $66.61
Upside: -
Oct 17, 2025
Rated: Hold
Price Target: n/a
Current: $42.09
Upside: -
Oct 9, 2025
Maintained: Buy
Price Target: n/a
Current: $286.29
Upside: -
Oct 8, 2025
Maintained: Buy
Price Target: n/a
Current: $64.21
Upside: -
Jul 23, 2025
Rated: Hold
Price Target: n/a
Current: $4.32
Upside: n/a
Jul 22, 2025
Maintained: Buy
Price Target: n/a
Current: $101.73
Upside: n/a
Jul 14, 2025
Maintained: Buy
Price Target: n/a
Current: $10.28
Upside: n/a
Feb 26, 2025
Maintained: Buy
Price Target: $12
Current: $11.10
Upside: n/a
Feb 5, 2025
Maintained: Buy
Price Target: n/a
Current: $5.25
Upside: n/a
Aug 28, 2024
Rated: Buy
Price Target: n/a
Current: $35.58
Upside: n/a
Aug 1, 2024
Maintained: Buy
Price Target: $38
Current: $20.38
Upside: n/a
Jul 18, 2024
Initiated Coverage: Buy
Price Target: n/a
Current: $13.94
Upside: n/a
Mar 21, 2024
Maintained: Buy
Price Target: $10
Current: $4.33
Upside: n/a
Oct 16, 2023
Rated: Buy
Price Target: n/a
Current: $4.96
Upside: n/a
Sep 13, 2023
Rated: Buy
Price Target: n/a
Current: $1.69
Upside: n/a
Aug 18, 2023
Rated: Buy
Price Target: n/a
Current: $24.95
Upside: n/a
May 4, 2023
Rated: Buy
Price Target: n/a
Current: $12.21
Upside: n/a
May 3, 2023
Rated: Buy
Price Target: $58
Current: $36.78
Upside: n/a